'Game-changing' Alzheimer's drug Lecanemab gets the green light - but it won't be available on the NHS

22 August 2024, 08:22 | Updated: 22 August 2024, 10:07

A woman receives Lecanemab, sold under the brand name Leqembi, at a hospital in Tokyo
A woman receives Lecanemab, sold under the brand name Leqembi, at a hospital in Tokyo. Picture: Alamy

By Asher McShane

The first drug that has been shown to slow the progression of Alzheimer's disease is set to be approved by the UK’s medicines regulator.

Listen to this article

Loading audio...

Lecanemab, developed by pharmaceutical company Eisai, is an antibody treatment that binds to amyloid, a protein which builds up in the brains of people living with Alzheimer's disease.

It is designed to help clear the build-up and slow down cognitive decline in people with the condition and is given to patients via an intravenous drip fortnightly.

The decision from the Medicines and Healthcare products Regulatory Agency (MHRA) is set to be announced shortly, but it is understood to have approved the treatment.

Read more: Search resumes in Sicily for last missing Bayesian superyacht passenger after five bodies found in wreck

Read more: Pictured: mum and 3 children aged 1, 5 and 9 who died in 'deliberate' Bradford house fire as man arrested for murder

It will also need the green light from health service spending watchdog the National Institute for Health and Care Excellence (Nice) before it is rolled out on the NHS in England.

Lecanemab is already licensed in the US, where it costs about £20,000 per patient per year, although it was rejected by the European Medicines Agency (EMA) in late July.

The EMA said the benefits of lecanemab did not counterbalance the risk of people suffering serious side-effects such as bleeding and swelling in the brain.

It also said the effects of the drug on delaying cognitive decline were small.

A similar drug called donanemab, which is developed by Eli Lilly, is also being assessed for approval in the UK by medicine regulators.

NHS England estimates between 50,000 and 280,000 patients might be eligible for the new treatments.

Prior to being given the drugs, they will need to have a baseline MRI scan and then either a Pet-CT scan or lumbar puncture to confirm Alzheimer's.

The ruling by the safety watchdog will mean it can be prescribed privately in Britain for the first time.

The National Institute of Health and Care Excellence will then advise on whether it should be rolled out by the NHS.

An MHRA spokesperson said: “We are currently completing a rigorous assessment of the evidence supporting lecanemab in the treatment of Alzheimer’s disease. Further information will be communicated in due course.”

Prof John Hardy, one of the world’s leading researchers in the field, said the drug was “game-changing”, describing it as “the biggest breakthrough in Alzheimer’s for decades”.

More Latest News

See more More Latest News

Exclusive
A small group of secondary school pupils working on practical experiments in a chemistry lab.

Ministers should consider shortening school holidays and letting teachers work from home, union chief says

JD Vance

Free speech is 'in retreat' across Europe, claims JD Vance - as US brands it a 'bigger threat than Russia'

oxford street with shoppers

Two arrested in Oxford St 'celebrity romance scam' after victims coerced into sending £200k to 'well-known boyfriends'

What if Ukraine were the UK? Could you accept surrendering a fifth of our country to Putin after so much sacrifice?

What if Ukraine were the UK? Could you accept surrendering a fifth of our country to Putin after so much sacrifice?

Most expensive pint revealed.

Most expensive pint in UK pubs revealed

One of the UK's 'most wanted' men sentenced to 12 years in prison after drug dealer evaded police for four years

One of the UK's 'most wanted' fugitives jailed for 12 years after drug dealer hunted down by police in Portugal

Anne Hodgson, 87, and Olwyn Smith, 82, with Dreamboy Max Hunter

Care home residents 'delighted' at male stripper visit

Police at the scene on the Broadway in Stratford

Three men stabbed in east London after 'large brawl' breaks out - with one arrested

The Met Office has issued a weather warning.

Snow and ice could cause disruption tomorrow, as Met Office issues yellow weather warning

Hostages (L-R) Sasha Trufanov, Sagui Dekel-Chen, and Yair Horn,

Hamas confirms names of Israeli hostages due for release on Saturday

Danielle McLaughlin's killer Baghat was finally found guilty today

Indian man is found guilty of raping and murdering Irish backpacker Danielle McLaughlin in a field in Goa

Starmer welcomes Volodymyr Zelenskyy, President of Ukraine, to Downing Street

Starmer tells Zelenskyy Ukraine remains on 'irreversible path to NATO membership' as leaders share phone call

Kayaker Adrian Simancas after being briefly swallowed by a humpback whale

Kayaker breaks silence over 'terrifying' moment he was swallowed whole by humpback whale - then spat back out

William and Kate shared the sweet snap for Valentine's Day

Princess Kate and Prince William share sweet snap to mark Valentine's Day

67th GRAMMY Awards - Arrivals

Kanye West and Bianca Censori shut down ‘split’ rumours as they plan Valentine’s Day together

Pope Francis

Pope Francis to be admitted to hospital for bronchitis treatment